Related Experiment Video
Updated: Jul 9, 2026

Automation of Bio-Atomic Force Microscope Measurements on Hundreds of C. albicans Cells
Published on: April 2, 2021
Increasing incidence of Candida parapsilosis candidemia with caspofungin usage
Graeme N Forrest1, Elizabeth Weekes, Jennifer K Johnson
1Division of Infectious Diseases, Department of Medicine, University of Maryland, 20 Penn Street, Room S403B, Baltimore, MD 21201, USA. gforrest@medicine.umaryland.edu
Objectives:
To determine the impact on the change in epidemiology of Candida species at our institution since the introduction of caspofungin.
Methods:
A 5-year retrospective review of all candidemia at a major tertiary care center. Only one episode of candidemia per patient per admission was counted. All antifungal defined daily doses were also collected in this same time period. Regression analysis was performed on the data and correlation statistics among antifungal use and Candida species were assessed using a Pearson correlation analysis.
Results:
There were 469 individual episodes of candidemia between fiscal year 2002 and 2006 with the rate increasing every year. On regression analysis there was a significant increase in Candida parapsilosis candidemia (R(2)=0.90, p=0.02) and significant increase in caspofungin usage (R(2)=0.80, p<0.01), with a correspondingly significant decline in conventional (R(2)=-0.77, p<0.01) and lipid amphotericin B (R(2)=-0.95, p<0.05) usage. We found correlations between increased caspofungin usage (R(2)=0.94, p=0.017) and increased C. parapsilosis candidemia and decreased Candida tropicalis candidemia (R(2)=0.92, p<0.05) and a trend towards decreased Candida glabrata (R(2)=0.64, p=0.1).
Conclusions:
We showed significant correlations between increased caspofungin usage and an increased incidence of C. parapsilosis candidemia and reduction in C. tropicalis candidemia, with a trend towards less C. glabrata candidemia.
Insights
The introduction of caspofungin correlated with increased Candida parapsilosis infections and decreased Candida tropicalis and Candida glabrata infections. This study highlights shifts in fungal epidemiology due to antifungal use.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Antimicrobial Stewardship
Background:
- The epidemiology of Candida species causing candidemia can change over time.
- Antifungal drug usage patterns may influence the prevalence of specific Candida species.
Purpose of the Study:
- To investigate the impact of caspofungin introduction on the epidemiology of Candida species.
- To analyze trends in candidemia and antifungal use over a five-year period.
Main Methods:
- Retrospective review of 469 candidemia episodes from 2002-2006.
- Collected data on antifungal defined daily doses.
- Utilized regression and Pearson correlation analyses to assess relationships between antifungal use and Candida species.
Main Results:
- A significant increase in Candida parapsilosis candidemia coincided with increased caspofungin usage.
- A significant decline in conventional and lipid amphotericin B usage was observed.
- Correlations found between higher caspofungin use and increased C. parapsilosis, decreased C. tropicalis, and a trend towards decreased C. glabrata.
Conclusions:
- Increased caspofungin use is significantly correlated with a rise in C. parapsilosis candidemia.
- A reduction in C. tropicalis candidemia was associated with caspofungin introduction.
- A trend towards decreased C. glabrata candidemia was noted alongside increased caspofungin usage.
Related Concept Videos
Candidiasis
Cryptococcal Meningitis
Antifungal Agents
Fungal Phylum Microsporidia
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

